Put companies on watchlist
Wacker Chemie AG
ISIN: DE000WCH8881
WKN: WCH888
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Wacker Chemie AG · ISIN: DE000WCH8881 · EQS - Company News (27 News)
Country: Germany · Primary market: Germany · EQS NID: 1294975
07 March 2022 11:30AM

Wacker Chemie AG: WACKER Resubmits RHYME Bavaria for European Union Funding


DGAP-News: Wacker Chemie AG / Key word(s): Sustainability
Wacker Chemie AG: WACKER Resubmits RHYME Bavaria for European Union Funding

07.03.2022 / 11:30
The issuer is solely responsible for the content of this announcement.


  • PROJECT IS A KEY BUILDING BLOCK IN MEETING THE GOAL OF NET-ZERO PRODUCTION BY 2045
  • SOME €100 MILLION TO BE INVESTED, WITH THE AMOUNT OF FUNDING APPLIED FOR IN THE DOUBLE-DIGIT MILLIONS
  • CEO CHRISTIAN HARTEL: "BY PRODUCING GREEN HYDROGEN AND USING IT AS A RAW MATERIAL, WE ARE MAKING AN ESSENTIAL CONTRIBUTION TOWARD MARKEDLY REDUCING FOSSIL RESOURCES IN CHEMICAL PROCESSES AND PRODUCTS"

Munich / Burghausen, March 7, 2022 - Wacker Chemie AG has re-applied for European Union funding for its project for producing green hydrogen and renewable methanol at its Burghausen site. The WACKER Group had applied for funding from the European Commission's EU Innovation Fund for its RHYME (Renewable Hydrogen and Methanol) Bavaria project in 2020. RHMYE Bavaria prevailed over more than two hundred other projects during the initial evaluation phase. Yet despite being given an excellent rating by the jury, it was unable to qualify during the final stage.

"The EU has now adjusted its selection criteria as well as increasing annual funding from €1 billion to €1.5 billion, which makes it possible to fund a medium-sized, albeit highly innovative project such as RHYME Bavaria," explained Christian Hartel, president and CEO of Wacker Chemie AG. "That's why we think resubmission of this trailblazing project stands a good chance of receiving the necessary EU funding. RHYME Bavaria is a key building block in meeting our ambitious climate-protection and sustainability targets. We want to halve our absolute greenhouse gas emissions by 2030 and achieve net-zero production by 2045."

RHYME Bavaria refers to a 20-megawatt electrolysis plant that will produce hydrogen from water using renewable electricity. WACKER intends to use carbon dioxide (CO2) from existing production processes to turn this green hydrogen into renewable methanol, a key starting material for making chemical products such as silicones.

The expected capacity of this plant is 15,000 metric tons of methanol per year. Compared with existing manufacturing processes, the new approach to methanol production could avoid CO2 emissions completely. The quantities of carbon dioxide required by RHYME Bavaria would no longer be emitted into the atmosphere. Instead, they would be recycled as a raw material in a chemical production process.

WACKER estimates it will invest some €100 million in the project, with the amount of EU funding applied for in the double-digit millions of euros. The EU's Innovation Fund has a budget of €10 billion to support innovative low-carbon technologies and processes in energy-intensive industries until 2030.

"Our RHYME Bavaria goal is to narrow our carbon footprint even further," explained CEO Christian Hartel. "By producing green hydrogen and using it as a material, we are making an essential contribution toward markedly reducing fossil resources in chemical processes and products."

Such a project was nevertheless still not economical under current conditions, Hartel continued. "That's why we need state funding to make the move to a renewable hydrogen economy possible." He added that investment grants weren't enough. Operating costs needed to be subsidized too, so that a plant such as RHYME Bavaria could be operated profitably in the first few years. What was needed in the medium term, he said, was an electricity price of about 4 cents per kilowatt-hour so that this kind of energy-intensive project did not require funding in order to be profitable.

"As an energy-intensive company, we have been in favor of an industrial electricity price for many years now in order to maintain our international competitiveness even as we accelerate our move toward net-zero status," he emphasized. "Our processes are among the most efficient in the world - making them some of the most economical too," he added. "Yet, in Germany, we have to pay an electricity price that is much higher than what our competitors in other parts of the world pay. That hits our entire industry hard."

Hartel went on to say that precisely the exorbitant rises in German electricity prices over recent months therefore showed how important an internationally competitive industrial electricity price was for export-driven sectors such as the chemical industry. The WACKER CEO also demanded a considerable and rapid expansion of renewable energy sources. Only in this way, he explained, sufficient amounts of competitively priced green hydrogen could be made available for projects such as RHYME Bavaria.

"A project such as RHYME Bavaria might be the initial step in defossilizing chemical processes and products in Bavaria's so-called chemical triangle," he added. The chemical triangle is a region in the southeast of Bavaria which is home to numerous chemical companies, including WACKER's Burghausen site. Today's integrated hydrogen network in the region could evolve over time into a Bavarian center for green hydrogen. Against this background, Hartel felt that it would be an important political signal if RHYME Bavaria - unlike the outcome of the initial evaluation phase - became the first German project to be subsidized by the EU Innovation Fund.

 

This press release contains forward-looking statements based on assumptions and estimates of WACKER's Executive Board. Although we assume the expectations in these forward-looking statements are realistic, we cannot guarantee they will prove to be correct. The assumptions may harbor risks and uncertainties that may cause the actual figures to differ considerably from the forward-looking statements. Factors that may cause such discrepancies include, among other things, changes in the economic and business environment, variations in exchange and interest rates, the introduction of competing products, lack of acceptance for new products or services, and changes in corporate strategy. WACKER does not plan to update its forward-looking statements, nor does it assume the obligation to do so.

 

For further information, please contact:
Wacker Chemie AG
Media Relations & Information
Christof Bachmair
Tel. +49 89 6279-1830
christof.bachmair@wacker.com



07.03.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Wacker Chemie AG
Hanns-Seidel-Platz 4
81737 München
Germany
Phone: 0049-89-6279-1633
Fax: 0049-89-6279-2933
E-mail: investor.relations@wacker.com
Internet: www.wacker.com
ISIN: DE000WCH8881
WKN: WCH888
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1294975

 
End of News DGAP News Service

1294975  07.03.2022 

fncls.ssp?fn=show_t_gif&application_id=1294975&application_name=news&site_id=boersengefluester_html
Visual performance / price development - Wacker Chemie AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.